Terri Wilder TheBodyPro Had a great discussion with Terri Wilder Terri Wilder from TheBodyPro at CROI 2024! We discussed our recent work on antigen persistence post-COVID, part of which was published last week in LancetID.

thebodypro.com/article/croi-2…

thelancet.com/journals/lanin…

Our website has a brand new, interactive call guide! It’s now easier than ever to find & contact your legislators to demand funding for #LongCovid .

Check it out: longcovidmoonshot.com/call-guide

Excited to share the first Long COVID Keystone report: Long COVID and post‐acute sequelae of SARS‐CoV‐2 pathogenesis and treatment: A Keystone Symposia report - Durstenfeld published in Annals of the New York Academy of Sciences nyaspubs.onlinelibrary.wiley.com/doi/10.1111/ny…

Truly could not be more excited for this 😭

Thank you Bernie Sanders for your leadership, thank you Michael Peluso, MD for calling for this with me in our Nature comment, and thank you Long Covid Moonshot & entire #LongCovid community for getting us to this point!

sanders.senate.gov/press-releases…

UC San Francisco #LIINC study on SCV2 protein persistence up to 14 mon post-COVID in The Lancet Infectious Diseases .

Now need to study this systematically in larger cohorts to pin down what it means. Does it have consequences? #LongCOVID ?

Thanks PolyBio NIH for support

thelancet.com/journals/lanin…

Great coverage of our UC San Francisco #hivcure work presented at CROI.

amfar.org/news/new-studi…

Give Congress a #LongCovid wake-up call!

On Thursday, March 14, we're calling our reps to demand a #LongCovid Moonshot—$1B+ in annual research funding to find treatment for the MILLIONS suffering without help.

Full call guide available our website 🚀

Really enjoyed working on this review of #LongCOVID systems immunology with collaborators from UC San Francisco, The Wistar Institute, and Gladstone Institutes. We did a deep dive into what's been done so far and laid out key questions for the next couple of years.

sciencedirect.com/science/articl…

Proud to be an author of this paper and member of the Consortium! We definitely need more resources to move clinical trials forward! Currently there are way too few and we have hundreds of people on our waitlist.

Even some of the most progressive politicians—yes, even the ones who talk of the 'lessons of HIV'—are silent on #LongCovid .

My story:

'I have long COVID—and Sen. Scott Wiener wouldn’t help.'

48hills.org/2024/01/i-have…

Scientists at Gladstone Institutes and UC San Francisco analyzed immune cells in people with and without long #COVID , making significant discoveries that will help answer questions about what causes the condition and how to treat it

bit.ly/3SfbGQX

I am proud to have signed onto this letter to President Biden asking him to address the crisis of #LongCovid and other infection-associated chronic conditions in his FY25 budget! We need a robust response now! x.com/patientled/sta…

I just called my reps Rep. Barbara Lee, Alex Padilla, & Senator Laphonza Butler to call for at least $1B in annual research funding for #LongCovid and support the current LC bills in Congress

Please join!
longcovidmoonshot.com

We are glad to have supported this study via our #LongCovid Research Consortium 👇The team primarily found activation of the alternative complement pathway in LongCovid, which can be triggered by persistent #pathogens or damaged tissue such as endothelium

Viral persistence is one of the leading hypotheses on what causes #LongCovid . Over the years we've done a lot of work to highlight, support, & grow this line of research. Some of this work:

1/

We are excited to announce a $15M gift from Kanro: a philanthropic fund to support scientific research established by Vitalik Buterin, co-founder of Ethereum: finance.yahoo.com/news/polybio-r…

Recent UC San Francisco #LIINC preprint finding SARS-CoV-2 antigen in plasma up to 14 months post-COVID. Samples prior to vaccine/reinfection. I now believe this is happening in at least some people. Major question - does this cause #LongCovid ? To be determined.

medrxiv.org/content/10.110…

The progress we have made on #LongCOVID so far is impressive. We need to keep it up. This means sustained investment in infection-associated chronic conditions research. Lisa McCorkell from Patient-Led Research Collaborative and I wrote about this in nature today.

nature.com/articles/d4158…

Amplifying this effort to share the stories of people experiencing #LongCOVID - The Long Covid Reader: The Book About Covid Long Haulers by Mary Ladd — Kickstarter kickstarter.com/projects/maryl…

Our first UC San Francisco #LongCOVID clinical trial targeting viral persistence with monoclonal antibodies featured by Nanette Asimov in the San Francisco Chronicle today.

I am grateful to Aerium Therapeutics Patient-Led Research Collaborative PolyBio for supporting this effort.

sfchronicle.com/health/article…